4 completed, 1 unknown. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 4, Unknown 1 |
Follow MenACWY: new trials by email Literature Review of MenACWY trials Research Report on MenACWY
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of GlaxoSmithKline Biologicals S.A's Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults rMenB+OMV NZ vaccine, Meningococcal Groups A, C, W and Y Conjugate Vaccine (MenACWY), Placebo - Infections, Meningococcal | Phase 3 | Completed | GlaxoSmithKline | 3657 | 2020-08-14 | 2024-03-05 |
| A Study of a Candidate COVID-19 Vaccine (COV003) ChAdOx1 nCoV-19 single dose + paracetamol, MenACWY single dose + paracetamol, ChAdOx1 nCoV-19 two dose + paracetamol - Coronavirus | Phase 3 | Unknown | University of Oxford | 10300 | 2020-06-02 | 2020-11-27 |
| Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo Ad26.ZEBOV, MVA-BN-Filo, MenACWY - Ebola Virus Disease | Phase 3 | Completed | Janssen Vaccines & Prevention B.V. | 1023 | 2015-09-30 | 2022-07-18 |
| Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy Infants Meningococcal group B Vaccine, rMenB+OMV NZ, Meningococcal ACWY Conjugate Vaccine, MenACWY - Infections, Meningococcal | Phase 3 | Completed | GlaxoSmithKline | 750 | 2014-06-05 | 2018-08-22 |
| Understanding the Immune Response to Meningitis Vaccines Meningococcal (Groups A, C, Y and W-135) Conjugate, Meningococcal polysaccharide A, C, Y and W135 and Menveo - Meningitis, Septicemia | Phase 3 | Completed | University of Oxford | 150 | 2009-06-01 | 2014-12-05 |
Meningitis (3) · Meningococcal Infections (2) · COVID-19 (1) · Central Nervous System Diseases (1) · Coronavirus Infections (1) · Hemorrhagic Fever, Ebola (1) · Hemorrhagic Fevers, Viral (1) · Nervous System Diseases (1) · Sepsis (1)
GlaxoSmithKline (2) · University of Oxford (2) · Janssen Vaccines & Prevention B.V. (1)
Argentina (1) · Australia (1) · Brazil (1) · Canada (1) · Czechia (1) · Estonia (1) · Finland (1) · Mexico (1) · Sierra Leone (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)
Andrew Pollard, FRCPCH, PhD (1) · Andrew Pollard, Prof (1)
PMID 29895178, PMID 34529962, PMID 34529963, PMID 37631885, PMID 38603720, PMID 39647494, PMID 39675209, PMID 40686533
2019 (2), 2016 (1)